During the past decade, Bluestar Genomics, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bluestar Genomics, Inc." are "Diagnosis of Cancer of Various Organs" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Bluestar Genomics, Inc." in a lesser frequency.

Most popular intervention types in "Bluestar Genomics, Inc." are "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Draw" (1 trials), "Early detection pancreatic cancer test" (1 trials) and "Early detection pancreatic cancer test and MRI Imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bluestar Genomics, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bluestar Genomics, Inc.". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bluestar Genomics, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bluestar Genomics, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".